322 related articles for article (PubMed ID: 21906355)
21. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy.
Fedak PW; Moravec CS; McCarthy PM; Altamentova SM; Wong AP; Skrtic M; Verma S; Weisel RD; Li RK
Circulation; 2006 Jan; 113(2):238-45. PubMed ID: 16401770
[TBL] [Abstract][Full Text] [Related]
22. Role of ADAM10 in intestinal crypt homeostasis and tumorigenesis.
Dempsey PJ
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2228-2239. PubMed ID: 28739265
[TBL] [Abstract][Full Text] [Related]
23. EGFR ligands and their signaling scissors, ADAMs, as new molecular targets for anticancer treatments.
Kataoka H
J Dermatol Sci; 2009 Dec; 56(3):148-53. PubMed ID: 19896805
[TBL] [Abstract][Full Text] [Related]
24. The cell-specific expression of metalloproteinase-disintegrins (ADAMs) in inflammatory myopathies.
Dehmel T; Janke A; Hartung HP; Goebel HH; Wiendl H; Kieseier BC
Neurobiol Dis; 2007 Mar; 25(3):665-74. PubMed ID: 17207628
[TBL] [Abstract][Full Text] [Related]
25. Considerations on inhibition approaches for proinflammatory functions of ADAM proteases.
Dreymueller D; Ludwig A
Platelets; 2017 Jun; 28(4):354-361. PubMed ID: 27460023
[TBL] [Abstract][Full Text] [Related]
26. Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17.
Deuss M; Reiss K; Hartmann D
Curr Alzheimer Res; 2008 Apr; 5(2):187-201. PubMed ID: 18393804
[TBL] [Abstract][Full Text] [Related]
27. Expression patterns of ADAMs in the developing chicken lens.
Yan X; Lin J; Rolfs A; Luo J
J Mol Histol; 2012 Apr; 43(2):121-35. PubMed ID: 22246534
[TBL] [Abstract][Full Text] [Related]
28. Putative function of ADAM9, ADAM10, and ADAM17 as APP alpha-secretase.
Asai M; Hattori C; Szabó B; Sasagawa N; Maruyama K; Tanuma S; Ishiura S
Biochem Biophys Res Commun; 2003 Jan; 301(1):231-5. PubMed ID: 12535668
[TBL] [Abstract][Full Text] [Related]
29. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
[TBL] [Abstract][Full Text] [Related]
30. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
[TBL] [Abstract][Full Text] [Related]
31. TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.
Gaweł-Bęben K; Ali N; Ellis V; Velasco G; Poghosyan Z; Ager A; Knäuper V
Cell Biol Int; 2018 Mar; 42(3):273-280. PubMed ID: 28762604
[TBL] [Abstract][Full Text] [Related]
32. Targeting the sheddase activity of ADAM17 by an anti-ADAM17 antibody D1(A12) inhibits head and neck squamous cell carcinoma cell proliferation and motility via blockage of bradykinin induced HERs transactivation.
Huang Y; Benaich N; Tape C; Kwok HF; Murphy G
Int J Biol Sci; 2014; 10(7):702-14. PubMed ID: 25013379
[TBL] [Abstract][Full Text] [Related]
33. Increased expression of ADAM family members in human breast cancer and breast cancer cell lines.
Lendeckel U; Kohl J; Arndt M; Carl-McGrath S; Donat H; Röcken C
J Cancer Res Clin Oncol; 2005 Jan; 131(1):41-8. PubMed ID: 15565459
[TBL] [Abstract][Full Text] [Related]
34. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D; Doege A; Alefeld E; Haase A; Beier M; Kiefer T; Biewald E; Metz K; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293469
[TBL] [Abstract][Full Text] [Related]
35. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
36. ADAMs family in kidney physiology and pathology.
Zhu H; Wang J; Nie W; Armando I; Han F
EBioMedicine; 2021 Oct; 72():103628. PubMed ID: 34653870
[TBL] [Abstract][Full Text] [Related]
37. Fluorescent substrates for the proteinases ADAM17, ADAM10, ADAM8, and ADAM12 useful for high-throughput inhibitor screening.
Moss ML; Rasmussen FH
Anal Biochem; 2007 Jul; 366(2):144-8. PubMed ID: 17548045
[TBL] [Abstract][Full Text] [Related]
38. Functional classification of ADAMs based on a conserved motif for binding to integrin alpha 9beta 1: implications for sperm-egg binding and other cell interactions.
Eto K; Huet C; Tarui T; Kupriyanov S; Liu HZ; Puzon-McLaughlin W; Zhang XP; Sheppard D; Engvall E; Takada Y
J Biol Chem; 2002 May; 277(20):17804-10. PubMed ID: 11882657
[TBL] [Abstract][Full Text] [Related]
39. Expression patterns of the ADAMs in early developing chicken cochlea.
Lin J; Yan X; Wang C; Talabattula VA; Guo Z; Rolfs A; Luo J
Dev Growth Differ; 2013 Apr; 55(3):368-76. PubMed ID: 23496030
[TBL] [Abstract][Full Text] [Related]
40. The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: novel drug targets with therapeutic potential?
Saftig P; Reiss K
Eur J Cell Biol; 2011; 90(6-7):527-35. PubMed ID: 21194787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
